I'm perfectly fine with it. If it was done at old series c terms, then no. I would much rather a long-term shareholder that believes in the company be offered such a deal than an IB, convertible noteholder, or similar that is only trying to make a fast buck at the expense of shareholders.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.